1. Jones MK, Oliver JD. Vibrio vulnificus: disease and pathogenesis. 2009. Infection and immunity 77:1723-1733.
2. Feldhusen F. The role of seafood in bacterial foodborne diseases. 2000. Microbes and infection / Institut Pasteur 2:1651-1660.
3. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, Griffin PM, Tauxe RV. 1999. Food-related illness and death in the United States. Emerging infectious diseases 5:607-625.
4. Sun J, Zheng J, Wang G, Li Y, Shen H. Apoptotic effect of Vibrio vulnificus cytolysin on A549 human lung adenocarcinoma cells. 2012. Molecular medicine reports 5:668-674.
5. Oliver JD. 2013. Vibrio vulnificus: death on the half shell. A personal journey with the pathogen and its ecology. Microbial ecology 65:793-799.
6. Horseman MA, Surani S. 2011. A comprehensive review of Vibrio vulnificus: an important cause of severe sepsis and skin and soft-tissue infection. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 15:e157-166.
7. Qin K, Fu K, Liu J, Wu C, Wang Y, Zhou L. 2019. Vibrio vulnificus cytolysin induces inflammatory responses in RAW264.7 macrophages through calcium signaling and causes inflammation in vivo. Microbial pathogenesis 137:103789.
8. Sugiyama H, Kashimoto T, Ueno S, Ehara H, Kodama T, Iida T, Susa N. 2011. Relationship between localization on cellular membranes and cytotoxicity of Vibrio vulnificus hemolysin. PloS one 6:e26018.
9. Lee SE, Ryu PY, Kim SY, Kim YR, Koh JT, Kim OJ, Chung SS, Choy HE, Rhee JH. 2004. Production of Vibrio vulnificus hemolysin in vivo and its pathogenic significance. Biochemical and biophysical research communications 324:86-91.
10. Kim HR, Rho HW, Jeong MH, Park JW, Kim JS, Park BH, Kim UH, Park SD. 1993. Hemolytic mechanism of cytolysin produced from V. vulnificus. Life sciences 53:571-577.
11. Yamanaka H, Satoh T, Katsu T, Shinoda S. 1987. Mechanism of haemolysis by Vibrio vulnificus haemolysin. Journal of general microbiology 133:2859-2864.
12. Jeong HG, Satchell KJ. 2012. Additive function of Vibrio vulnificus MARTX(Vv) and VvhA cytolysins promotes rapid growth and epithelial tissue necrosis during intestinal infection. PLoS pathogens 8:e1002581.
13. Wang MY, Liu XF, Xia J, Li Y, Geng JL, Hu CJ. 2017. Vibrio vulnificus VvhA induces Th1 and Tfh cells to proliferate against Vibrio vulnificus in a mouse model of infection. Future microbiology 12:953-965.
14. Fazilleau N, Mark L, McHeyzer-Williams LJ, McHeyzer-Williams MG. 2009. Follicular helper T cells: lineage and location. Immunity 30:324-335.
15. Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G, Foucat E, Dullaers M, Oh S, Sabzghabaei N et al. 2011. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 34:108-121.
16. Spolski R, Leonard WJ. 2008. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annual review of immunology 26:57-79.
17. Spolski R, Kashyap M, Robinson C, Yu Z, Leonard WJ. 2008. IL-21 signaling is critical for the development of type I diabetes in the NOD mouse. Proceedings of the National Academy of Sciences of the United States of America 105:14028-14033.
18. Kuchen S, Robbins R, Sims GP, Sheng C, Phillips TM, Lipsky PE, Ettinger R. 2007. Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration. Journal of immunology 179:5886-5896.
19. Chen Y, Yu M, Zheng Y, Fu G, Xin G, Zhu W, Luo L, Burns R, Li QZ, Dent AL et al. 2019. CXCR5(+)PD-1(+) follicular helper CD8 T cells control B cell tolerance. Nature communications 10:4415.
20. Rasheed MA, Latner DR, Aubert RD, Gourley T, Spolski R, Davis CW, Langley WA, Ha SJ, Ye L, Sarkar S et al. 2013. Interleukin-21 is a critical cytokine for the generation of virus-specific long-lived plasma cells. Journal of virology 87:7737-7746.
21. Fan W, Wan Y, Li Q. 2020. Interleukin-21 enhances the antibody avidity elicited by DNA prime and MVA boost vaccine. Cytokine 125:154814.
22. Fazilleau N, Eisenbraun MD, Malherbe L, Ebright JN, Pogue-Caley RR, McHeyzer-Williams LJ, McHeyzer-Williams MG. 2007. Lymphoid reservoirs of antigen-specific memory T helper cells. Nature immunology 8:753-761.
23. Nance JP, Belanger S, Johnston RJ, Takemori T, Crotty S. 2015. Cutting edge: T follicular helper cell differentiation is defective in the absence of Bcl6 BTB repressor domain function. Journal of immunology 194:5599-5603.
24. Crotty S. 2014. T follicular helper cell differentiation, function, and roles in disease. Immunity 41:529-542.
25. Hennessy EJ, Parker AE, O'Neill LA. 2010. Targeting Toll-like receptors: emerging therapeutics? Nature reviews Drug discovery 9:293-307.
26. Liu CH, Liu H, Ge B. 2017. Innate immunity in tuberculosis: host defense vs pathogen evasion. Cellular & molecular immunology 14:963-975.
27. Jian W, Gu L, Williams B, Feng Y, Chao W, Zou L. 2019. Toll-like Receptor 7 Contributes to Inflammation, Organ Injury, and Mortality in Murine Sepsis. Anesthesiology 131:105-118.
28. Maeda K, Akira S. 2016. TLR7 Structure: Cut in Z-Loop. Immunity 45:705-707.
29. Bagnoli F, Fontana MR, Soldaini E, Mishra RP, Fiaschi L, Cartocci E, Nardi-Dei V, Ruggiero P, Nosari S, De Falco MG et al. 2015. Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus. Proceedings of the National Academy of Sciences of the United States of America 112:3680-3685.
30. Kurihara T, Warr G, Loy J, Bravo R. 1997. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. The Journal of experimental medicine 186:1757-1762.
31. Vangelista L, Vento S. 2017. The Expanding Therapeutic Perspective of CCR5 Blockade. Frontiers in immunology 8:1981.